Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) Operating Margin: 2009-2025

Historic Operating Margin for Madrigal Pharmaceuticals (MDGL) over the last 9 years, with Sep 2025 value amounting to -39.68%.

  • Madrigal Pharmaceuticals' Operating Margin rose 14738.00% to -39.68% in Q3 2025 from the same period last year, while for Sep 2025 it was -41.52%, marking a year-over-year increase of 75272.00%. This contributed to the annual value of -276.39% for FY2024, which is 326960.00% down from last year.
  • Per Madrigal Pharmaceuticals' latest filing, its Operating Margin stood at -39.68% for Q3 2025, which was down 78.87% from -22.18% recorded in Q2 2025.
  • In the past 5 years, Madrigal Pharmaceuticals' Operating Margin ranged from a high of 15,377.02% in Q2 2022 and a low of -124,232.69% during Q4 2021.
  • For the 3-year period, Madrigal Pharmaceuticals' Operating Margin averaged around 1,325.06%, with its median value being -22.18% (2025).
  • Per our database at Business Quant, Madrigal Pharmaceuticals' Operating Margin slumped by 11,044,681bps in 2021 and then spiked by 13,830,843bps in 2022.
  • Over the past 5 years, Madrigal Pharmaceuticals' Operating Margin (Quarterly) stood at -124,232.69% in 2021, then surged by 13,830,843bps to 14,075.74% in 2022, then slumped by 1,112,495bps to 2,950.79% in 2023, then crashed by 301,564bps to -64.84% in 2024, then surged by 14,738bps to -39.68% in 2025.
  • Its last three reported values are -39.68% in Q3 2025, -22.18% for Q2 2025, and -57.79% during Q1 2025.